NASDAQ Globe Newswire:  “Over the last few years I have been the subject of an SEC investigation surrounding a prior venture, Medbox, Inc. during 2012-2014. . . . I received bad advice from the company’s [Medbox’] attorney . . . . I have become a target for any alleged missteps Medbox’s accountants, CFO, and auditor may have made, which was both caused and worsened by the incompetent attorney’s advice . . . . Given the Medbox circumstances and a curious trading suspension handed down by the SEC on PNPL securities, it appears that any venture that I’m actively involved with may be targeted unjustly.”